161 related articles for article (PubMed ID: 1803227)
1. Combination therapy in a model of pulmonary aspergillosis.
Schmitt HJ; Bernard EM; Edwards FF; Armstrong D
Mycoses; 1991; 34(7-8):281-5. PubMed ID: 1803227
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
4. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
Clemons KV; Stevens DA
Med Mycol; 2006 Feb; 44(1):69-73. PubMed ID: 16805095
[TBL] [Abstract][Full Text] [Related]
6. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
Steinbach WJ; Stevens DA; Denning DW
Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Denning DW; Hall L; Jackson M; Hollis S
Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
[TBL] [Abstract][Full Text] [Related]
8. Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
Ribner B; Keusch GT; Hanna BA; Perloff M
Chest; 1976 Nov; 70(5):681-3. PubMed ID: 789031
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.
Leenders AC; de Marie S; ten Kate MT; Bakker-Woudenberg IA; Verbrugh HA
J Antimicrob Chemother; 1996 Aug; 38(2):215-25. PubMed ID: 8877535
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.
Sionov E; Mendlovic S; Segal E
J Infect; 2006 Aug; 53(2):131-9. PubMed ID: 16360214
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Longman LP; Martin MV
J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of experimental invasive pulmonary aspergillosis in rats with liposomal amphotericin B].
Matsuda H; Kohno S; Miyazaki Y; Mitsutake K; Tanaka K; Maesaki S; Iwamoto M; Hashimoto A; Kaku M; Koga H
Kansenshogaku Zasshi; 1993 Feb; 67(2):102-9. PubMed ID: 8468494
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
18. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Manavathu EK; Cutright JL; Chandrasekar PH
Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
[TBL] [Abstract][Full Text] [Related]
19. Inactivity of terbinafine in a rat model of pulmonary aspergillosis.
Schmitt HJ; Andrade J; Edwards F; Niki Y; Bernard E; Armstrong D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):832-5. PubMed ID: 2128278
[TBL] [Abstract][Full Text] [Related]
20. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
